Location: Home
  • search
  • go
  • Relate News
  • 12/28/2018NMPA Issues Notice on Strengthening Drug Regulation During Centralized...
  • 12/27/2018SAMR to Raise Compensation for Flawed Products Endangering Life and He...
  • 12/27/2018CK: China's Pharma Industry Investment to Reach US$100B in 2019
  • 12/27/2018JHL Biotech Announces First Patient Randomized in the Phase III Study ...
  • 12/27/2018NMPA Approves Innovent's Anti-PD-1 Antibody Tyvyt (Sintilimab) for Hod...
  • 12/27/2018India Demands Preferential Treatment of Indian Drugs Approved by Regul...
  • 12/27/2018Merck KGaA Terminates Partnership with BeiGene for Lifirafenib
  • 12/25/2018China Issues First Nationwide Negative List, Pledging Equal Treatment ...
  • 12/25/2018Chinese Government Pledges to Raise Healthcare Investment
  • 12/25/2018China Removes Import Tariff of 700 Items Including At Least 50+ Drug I...
  • 12/24/2018China Biotech: Six Things to Watch in 2019
  • 12/24/2018Draft Patent Law Amendment Under First Review by the NPC (with Key Pha...
  • 12/24/2018NPC Reviews Draft Foreign Investment Law to Ban Forced Technology Tran...
  • 12/24/2018NMPA Publishes the Second List of Drugs with Expired, Terminated or In...
  • 12/24/2018NHC: National S&T Major Project for New Drug R&D Harvests Abun...
  • 12/23/2018Recent Executive Moves
  • 12/21/2018SMIA Initiates Process for National DRG Trial
  • 12/20/2018HitGen and Bayer Enter DNA-Encoded Library Based Research Collaboratio...
  • 12/20/2018IQVIA: Chinese Hospital Drug Market Up 2.8% in MAT Q3/2018
  • 12/20/2018China to Introduce Implementation Rules for 4+7 National Volume-linked...
  • 12/20/2018NMPA Solicits Comments on Draft Requirements for Import Drug Standard ...
  • 12/19/2018Ziopharm Oncology and TriArm to Form Joint Venture for China and Korea
  • 12/19/2018AC Immune and WuXi Biologics to Establish an Exclusive Strategic Partn...
  • 12/19/2018Novartis, Gan & Lee Push into Insulin amid Diabetes Epidemic
  • 12/19/2018Ascentage Pharma Announces Strategic Collaboration with Genor Biopharm...
  • 12/18/2018New Pfizer CEO's Top Priorities? Think China and Pipeline, Not Deals
  • 12/18/2018China's Win-At-All-Costs Approach Suggests It Will Follow Its Own Dang...
  • 12/18/2018Grifols Eyes $5B Takeover of Shanghai RAAS Blood Products
  • 12/17/2018I-Mab and CSPC Pharma Announce Strategic Alliance for Long-acting GLP-...
  • 12/17/2018Roche Wins Chinese Approval of Anticancer Perjeta (Pertuzumab)
  • Page:149/357 Total number of articles:10698: [First][<<] [147] [148] [149] [150] [151] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group